BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12575826)

  • 1. Neurotrophins.
    Dechant G; Neumann H
    Adv Exp Med Biol; 2002; 513():303-34. PubMed ID: 12575826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting neurotrophic effects by GPCR ligands.
    Jeanneteau F; Chao MV
    Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases.
    Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S
    Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotrophic factors: basis for their clinical application].
    Morís G; Vega JA
    Neurologia; 2003; 18(1):18-28. PubMed ID: 12590377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting neurotrophin receptors in the central nervous system.
    Mocchetti I; Brown M
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):71-82. PubMed ID: 18289034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophin signalling in health and disease.
    Chao MV; Rajagopal R; Lee FS
    Clin Sci (Lond); 2006 Feb; 110(2):167-73. PubMed ID: 16411893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of the neurotrophins and their receptors.
    Allen SJ; Dawbarn D
    Clin Sci (Lond); 2006 Feb; 110(2):175-91. PubMed ID: 16411894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases.
    Mufson EJ; Kroin JS; Sendera TJ; Sobreviela T
    Prog Neurobiol; 1999 Feb; 57(4):451-84. PubMed ID: 10080385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophin signalling: novel insights into mechanisms and pathophysiology.
    Mitre M; Mariga A; Chao MV
    Clin Sci (Lond); 2017 Jan; 131(1):13-23. PubMed ID: 27908981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of neurotrophins with the p75NTR common neurotrophin receptor: a comprehensive molecular modeling study.
    Shamovsky IL; Ross GM; Riopelle RJ; Weaver DF
    Protein Sci; 1999 Nov; 8(11):2223-33. PubMed ID: 10595525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance.
    Rahman MM; Islam MR; Supti FA; Dhar PS; Shohag S; Ferdous J; Shuvo SK; Akter A; Hossain MS; Sharma R
    Mol Neurobiol; 2023 Aug; 60(8):4206-4231. PubMed ID: 37052791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal and nonneuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia suggest new intercellular trophic interactions.
    Wetmore C; Olson L
    J Comp Neurol; 1995 Feb; 353(1):143-59. PubMed ID: 7714245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe peripheral sensory neuron loss and modest motor neuron reduction in mice with combined deficiency of brain-derived neurotrophic factor, neurotrophin 3 and neurotrophin 4/5.
    Liu X; Jaenisch R
    Dev Dyn; 2000 May; 218(1):94-101. PubMed ID: 10822262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins.
    Mendoza E; Miranda-Barrientos JA; Vázquez-Roque RA; Morales-Herrera E; Ruelas A; De la Rosa G; Flores G; Hernández-Echeagaray E
    Neuroscience; 2014 Nov; 280():156-70. PubMed ID: 25241069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurotrophins and their receptors: structure, function, and neuropathology.
    Maness LM; Kastin AJ; Weber JT; Banks WA; Beckman BS; Zadina JE
    Neurosci Biobehav Rev; 1994; 18(1):143-59. PubMed ID: 8170621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.
    Naoi M; Maruyama W
    Curr Pharm Des; 2010; 16(25):2799-817. PubMed ID: 20698822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.
    Pramanik S; Sulistio YA; Heese K
    Mol Neurobiol; 2017 Nov; 54(9):7401-7459. PubMed ID: 27815842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases.
    Bronfman FC; Escudero CA; Weis J; Kruttgen A
    Dev Neurobiol; 2007 Aug; 67(9):1183-203. PubMed ID: 17514710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of apoptotic but not necrotic cell death following neuronal injury by neurotrophins signaling through the tyrosine kinase receptor.
    Kim DH; Zhao X; Tu CH; Casaccia-Bonnefil P; Chao MV
    J Neurosurg; 2004 Jan; 100(1):79-87. PubMed ID: 14743916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical interneurons upregulate neurotrophins in vivo in response to targeted apoptotic degeneration of neighboring pyramidal neurons.
    Wang Y; Sheen VL; Macklis JD
    Exp Neurol; 1998 Dec; 154(2):389-402. PubMed ID: 9878177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.